Waters and Bruker seek integration

By Gregory Roumeliotis

- Last updated on GMT

Related tags Mass spectrometry High performance liquid chromatography

Analytical technology specialists Waters Corporation and Bruker
BioSciences have entered into a collaboration agreement to provide
greater integration and connectivity between their products,
looking to increase efficiency in pharmaceutical manufacturing.

The deal will seek to streamline the usage of Waters's ultra performance LC system with Bruker's mass spectrometry (MS) and nuclear magnetic resonance (NMR) products.

This will be attractive to customers of both companies because mass spectrometry results are highly dependent on the liquid chromatography separation preceding ionisation and confirmatory analysis in the mass spectrometer.

"Scientists are always looking for a competitive edge and many haveexperienced the advantages of using UPLC with MS,"​ said Rohit Khanna, Water's vice president for worldwide marketing.

"Combining UPLC with mass spectrometry brings scientists measurable improvements in performance and in the overall quality of information they obtain from their LC/MS and LC/NMR analyses resulting in improved decision-making, increased productivity and reduced business risk."

UPLC results are significantly better than those obtained by conventional high performance liquid chromatography (HPLC) since peaks are narrower and sharper, signal-to-noise ratios are higher, peak capacity is greater and run times are shorter.

These are all key factors in reducing the effects of ion suppression and enhancing the performance of virtually any mass spectrometer, thus bringing laboratories new levels of efficiency.

The two companies hope the seamless combination of UPLC technology with mass spectrometry will bring to the laboratories of their clients more information per unit of time, resulting in greater productivity.

Waters says the liquid chromatography, mass spectrometry, and thermal analysis sectors account for $4.5bn (€3.6bn) to $5bn of the overall $20bn+ analytical instrumentation market.

Apart from pharmaceutical manufacturing, the products of both companies play an important role in drug discovery as well in environmental and food safety laboratories and the production of processed foods, beverages and personal care products.

Related news

Show more

Related product

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.